SEOUL, Jan. 31 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and ...

Operator Greetings, welcome to Dynatrace fiscal third quarter 2025 earnings call. [Operator instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Noelle ...